NCT05068206 2021-10-20A Clinical Study to Compare the Efficacy and Safety of AK105 Plus Anlotinib and Capecitabine/Oxaliplatin (CapeOx) , Anlotinib Plus CapeOx, Bevacizumab Plus CapeOxChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 2 Unknown120 enrolled